Epithelial–mesenchymal transition in cancer development and its clinical significance

By M. Iwatsuki, K. Mimori, T. Yokobori, Hideshi Ishi, T. Beppu, S. Nakamori, H. Baba, M. Mori. Cancer Science, 2010

739 citations recorded by the source corpus.

Subfields: Genetics, Molecular Biology, Oncology

View Paper: https://www.semanticscholar.org/paper/b07b67bf37ec9f81ced4d92eabf88d18d50ed992

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Molecular Biology

1. J. Roh

Citations in the corpus

• EMT and tumor metastasis (2015, neutral): “6% Snail, Twist, Zeb1, Zeb2, E-cadherin, CCR7, Claudin-1, Fibronectin, Klf8, miR-9, miR-34, miR-200, N-cadherin, Occludin, PTEN, Slug, STK11, [62,63,66,72,79-82]”
• Epithelial-Mesenchymal Transition (2014, background): “can acquire invasive properties and enter the surrounding stroma, resulting in the creation of a favorable microenvironment for cancer progression and metastasis.(16) Loss of E-cadherin expression, which leads to reduced cell-cell adhesion, and elevated levels of mesenchymal markers such as vimentin”